Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nuvectis Pharma Inc.

    NASDAQ: NVCT · Real-Time Price · USD
    6.47
    0.04 (0.62%)
    At close: Aug 15, 2025, 3:59 PM
    6.43
    -0.62%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Nuvectis Pharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Net Income
    		 -22.07M -20.16M -19M -19.37M -21.1M -22.38M -22.26M -22.33M -22.33M -20.19M -19.09M -14.65M -13.44M -15.81M -12.89M -10.63M -5.96M -23K
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 -1.92M 1.19M 1.12M 1.2M 4.91M 4.6M 4.71M 3.97M 3.39M 2.95M 1.71M 1.41M 987K 2.05M 1.89M 1.71M 1.57M n/a
    Other Working Capital
    		 1.13M 1.94M 2.17M 1.29M 2.62M 3.24M 1.58M 2.75M 1.24M 1.08M 2.38M -785.56K -679K -839K -8K 462K 356K n/a
    Other Non-Cash Items
    		 4.73M 4.17M 6.48M 7.68M 5.82M 5.59M 4.68M 3.97M 2.84M 2.4M 1.15M 852.51K 987K 2.05M 1.92M 1.73M 1.59M 23K
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 5M 3.92M 2.64M 1.55M 1.72M 2.25M 1.6M 2.75M 2.14M 1.98M 3.82M 2.13M 1.34M 1.18M 1.49M 485K 379K 23K
    Operating Cash Flow
    		 -12.41M -12.06M -12.25M -13.63M -14.47M -15.54M -15.95M -15.62M -16.8M -15.26M -13.56M -11.11M -11.11M -12.58M -9.5M -8.44M -4.01M n/a
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.47M -1.52M -382K -242K -615K 9.39M 9.8M 9.65M 8.69M -1.84M -4.07M -3.94M -2.55M 9.25M 11.22M 11.22M 11.22M n/a
    Financial Cash Flow
    		 21.09M 22.46M 11.65M 8.74M 7.99M 19.53M 15.09M 14.04M 27.83M 14.04M 27.81M 27.94M 17.47M 29.27M 15.25M 15.25M 11.22M n/a
    Net Cash Flow
    		 8.68M 10.4M -593K -4.89M -6.48M 4M -867K -1.58M 11.03M -1.23M 14.25M 16.83M 6.36M 16.69M 5.74M 6.81M 7.21M n/a
    Free Cash Flow
    		 -12.41M -12.06M -12.25M -13.63M -14.47M -15.54M -15.95M -15.62M -16.8M -15.26M -13.56M -11.11M -11.11M -12.58M -9.5M -8.44M -4.01M n/a

    Add to Watchlist